May 11–15, 2026
CSTF is presenting at Human Tech Week. Meet the speakers joining us.
Alex Feerst is a technology lawyer who has represented startups in areas including AI, robotics, and neurotech. He was the General Counsel of Neuralink and is currently Chief Legal Officer at Science Corporation.
Andreas Tolias is a Stanford faculty member and co-lead of the Enigma Project, whose research bridges neuroscience and AI to reverse-engineer the principles of natural intelligence, from perceptual inference to decision-making. His lab integrates systems and computational neuroscience to build AI systems that are more robust, trustworthy, and efficient.
Emma Zhou is a co-founder and Director of BCI Research at Science Corp, where she leads the team applying advanced BCI technologies in complex behavioral experiments. She brings over two decades of software engineering experience, specializing in neural engineering since 2018 with prior work at Neuralink.
Felix is cofounder and CEO of a stealth neolab in Cambridge MA building new models that learn, think, and act like individual people. He finished his PhD in computational cognitive science between Harvard and MIT and previously worked on physical world-modeling at the MIT-IBM Watson Lab and LM coding agents at Deepmind.
Jonathan Kreindler is President and Co-founder of Receptiviti, a company that measures human cognitive and psychological state in AI systems from language signals. His work enables AI to evaluate, adapt to, and better serve users in real-world applications.
Jonathan Xu is the founder of Alljoined, a deep tech company applying deep learning to non-invasive neural data to build brain-computer interfaces that enable humans to interact with technology at the speed of thought. Before founding Alljoined, he co-authored the seminal neural decoding paper MindEye 2.
Julie Cachia earned her PhD in Affective Science at Stanford and is a co-founder of Flourish Science. She translates psychological research into AI-powered mental health tools and leads large-scale randomized controlled trials evaluating their effects on well-being.
Matt Goerzen is a PhD candidate in the History of Science at Harvard University, and an affiliate of the Berkman Klein Center for Internet and Society. He was previously a researcher at the Data & Society Research Institute, where he developed a framework for discussing vulnerabilities in social media.
Dr. Mylea Charvat is a Stanford-trained clinical neuroscientist and founder specializing in AI-enabled diagnostics and mental health technology. With over two decades of experience spanning neuromodulation, FDA regulatory strategy, and go-to-market execution, she partners with medical device and AI-enabled care delivery companies to bridge clinical science and commercial reality.
Nathalie Gouailhardou is a neuroscientist and co-founder and CEO of Neurode, a company developing a wearable headset that uses brain stimulation and imaging to treat and track symptoms of neurological conditions like ADHD. Inspired by her own diagnosis and her research with non-invasive brain imaging at the Bionics Institute, she is on a mission to bring lab-grade neurotechnology to everyday consumers at a fraction of the cost.
Dr. Walter G. Johnson is a Fellow at Stanford Law School's Center for Law and the Biosciences, where his research examines the legal implications of emerging technologies in biomedicine. His current work focuses on global neurotechnology governance, regulatory sandboxes, and FDA law and policy.